UPS
43
-2
C
84
3
MLM
58
5
KR
56
-4
APH
86
2
MDLZ
44
-2
D
38
-5
THC
66
4
AEP
53
-5
RIG
35
-2
FLS
71
2
UAL
61
4
PG
58
-3
KMX
52
2
PNW
49
-6
NSC
71
4
QRVO
69
-2
CCL
81
3
ACN
65
2
EQT
59
2
UPS
43
-2
C
84
3
MLM
58
5
KR
56
-4
APH
86
2
MDLZ
44
-2
D
38
-5
THC
66
4
AEP
53
-5
RIG
35
-2
FLS
71
2
UAL
61
4
PG
58
-3
KMX
52
2
PNW
49
-6
NSC
71
4
QRVO
69
-2
CCL
81
3
ACN
65
2
EQT
59
2
Financhill
Back

Regenxbio Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
33

RGNX
Regenxbio

Last Price:
$8.39
Seasonality Move:
4.55%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here

Regenxbio Stock Forecast

  • Over the next 52 weeks, Regenxbio has on average historically risen by 8.2% based on the past 9 years of stock performance.
  • Regenxbio has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Regenxbio Stock Undervalued?
    The current Regenxbio [RGNX] share price is $8.18. The Score for RGNX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Regenxbio Stock Go Up Next Year?

  • Over the next 52 weeks, Regenxbio has on average historically risen by 8.2% based on the past 9 years of stock performance.

Regenxbio Stock Rating

Sell
33
Regenxbio (RGNX) is a Sell

Is Regenxbio overpriced?

  • Regenxbio has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Regenxbio Stock Price History

Is RGNX stock going to rise?

  • The current trend is moderately bearish and RGNX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regenxbio.com

52-Week Data

52-Week High:
16.85
52-Week Low:
5.04

Prediction Charts

Market Cap:
409.7M
Price in USD:
8.18
Volume:
2.9M
Beta:
1.11

Technical Analysis

SMA50:
7.42
SMA100:
7.53
SMA200:
9.25
52-Wk Change:
-48.03%

Stock Predictions

  • Is Regenxbio stock public?
    Yes, Regenxbio is a publicly traded company.
  • What is the Regenxbio stock quote today?
    The Regenxbio stock price is 8.18 USD today.
  • How to buy Regenxbio stock online?
    You can buy Regenxbio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 8.83 9.20 9.31 8.52
Apr-25 9.10 9.15 9.23 8.77
Apr-28 9.15 9.13 9.37 8.90
Apr-29 9.09 9.41 9.48 8.96
Apr-30 9.18 9.61 9.72 9.01
May-1 9.60 9.83 9.93 9.27
May-2 9.97 10.40 10.59 9.94
May-5 10.36 9.76 10.43 9.65
May-6 9.61 7.92 9.74 7.86
May-7 7.91 7.24 7.94 6.99
May-8 7.21 7.15 7.38 6.89
May-9 7.23 7.52 7.78 7.23
May-12 7.96 7.97 8.20 7.63
May-13 7.97 8.18 9.02 7.78

Regenxbio Earnings

Regenxbio Earnings Report: Per Share Regenxbio Earnings Q1 Q2 Q3 and Q4 last year and next year.

Regenxbio Forecast Revenue Growth

Regenxbio Stock Analysis: Historical quarterly revenues per share for Regenxbio and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.86 per share, a decrease next quarter of $2.08 per share, an increase this year of $5.68 per share, and a decrease next year of $2.20 per share.

* Regenxbio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.